News

Caretaker Medical Unveils VitalStream Roadmap for Streamlined Cardiogenic Shock Monitoring at SCAI 2024

Caretaker Medical, a leading innovator in advanced hemodynamic monitoring solutions, today announced the launch of its VitalStream® Cardiogenic Shock Continuous Monitoring Roadmap at the Society for Cardiovascular Angiography and Interventions (SCAI) 2024 meeting. This roadmap aligns with the National Cardiogenic Shock Initiative[i] criteria and timelines, empowering clinicians with a streamlined approach to early identification, and management of cardiogenic shock (CS).

Cardiogenic shock is a deadly condition where the heart abruptly weakens and cannot pump enough blood to meet the body’s needs. With a mortality rate as high as 50%[ii], early identification is critical for improving patient outcomes. Yet, timely diagnosis of CS remains a challenge.

“The VitalStream Roadmap empowers clinicians to combat this silent killer,” said Jeff Pompeo, CEO of Caretaker Medical. “By simplifying the monitoring process and providing real-time hemodynamic insights within 90 seconds of application, VitalStream can potentially save lives.”

VitalStream: Immediate and Continuous Monitoring for Faster, More Informed Decisions

The VitalStream Roadmap guides clinicians through a standardized process for CS identification using VitalStream, a continuous non-invasive monitoring system. VitalStream offers several key advantages over traditional methods:

  • Rapid Setup: Streamlined application within 90 seconds minimizes time to critical data.
  • Comprehensive Monitoring: Continuously monitors advanced hemodynamics including Blood Pressure (BP), Cardiac Output (CO), Cardiac Power Output (CPO), Heart Rate (HR), Stroke Volume (SV), and Systemic Vascular Resistance (SVR).
  • Dynamic Therapy Response: Provides Delta Values (Delta CO, Delta CPO, Delta MAP, Delta SV, Delta SVR) to enable clinicians to assess a patient’s response to therapy in real-time, guiding ongoing management decisions.

Aligning with National Cardiogenic Shock Initiative

The VitalStream Roadmap is designed to support the goals of the National Cardiogenic Shock Initiative, a program focused on improving CS care through early identification, standardized treatment protocols, and quality improvement measures. By aligning with the Initiative’s criteria and timelines, VitalStream can help hospitals enhance their CS care pathways.

 

Learn more here.

Recent News

12/19/2024

Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announces FDA clearance to initiate a new additional Netherton Syndrome (NS) clinical study for QRX003. QRX003 is a topical lotion that contains a broad-spectrum serine protease inhibitor designed to target the kallikreins in

12/11/2024

Liquet™ Medical Inc. Receives FDA 510(k) Clearance for the Versus™ Catheter

Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Versus™ Catheter. This innovative medical device is set to enhance the treatment of pulmonary artery blood clots by offering real-time pulmonary artery

12/03/2024

ivWatch Named to Inc.’s 2024 Best in Business List in Health Products Category

ivWatch, LLC, the IV safety company, is proud to announce it has been named to the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries and on society at large.